Todd Eldredge currently serves as President and Chief Executive Officer at CardioRisk as well as a member of its board of directors. Todd directs all activities of the company with a focus on New Technology, Quality, and Marketing. Todd brings over 20 years of industry senior and executive management experience to the company. Most of this experience was within the pharmaceutical and other high-tech industries. Todd has served in executive management positions at STSN (iBaun), Document Control Systems (Master Control), Sanofi-Aventis and Rhone Poulenc. Prior to joining CardioRisk, Todd served as Vice President of Sales and Vice President / General Manager for a successful start-up that became the worldwide leader of services for business travelers. In this capacity he was actively engaged in growing their revenue from $1MM to over $100MM/year. He also served as Vice President of Sales and Marketing at Document Control Systems (now Master Control) an enterprise quality systems software solution for Fortune 1000 companies. Prior to DCS, Todd ran a business unit for Rhone-Poulenc, which was eventually purchased by Aventis (now Sanofi-Aventis), a publicly-traded company. Todd holds an MBA from Brigham Young University, an MPH, and a PhD in cardiovascular-epidemiology. He also the author of the #1 best selling book “Cardiovascular Wellness Management Success Plan”.
Prior to coming to CardioRisk Laboratories, Ken held multiple senior and executive management positions in publicly traded and large privately held companies whose revenues exceeded $350MM/year. Most recently he ran a successful business unit for Rhone-Poulenc. In this role he increased sales by over 300% in just under 3 years. He was also the US Director of Telesales for Sanofi Pastuer, and increased sales in this role by over 200% in two years while reducing expenses. Ken is an entrepreneur and started several companies including a successful Real Estate Management firm and more recently an Emergency Services Company where he had a successful exit which led to his retirement in 2013. In March of 2018, Ken received a CardioRisk Carotid artery Intima-Media Thickness (CIMT) exam and witnessed firsthand the lifesaving benefits of this technology. Weeks later he was persuaded out of a peaceful retirement to join the executive team at CardioRisk to help expand the usage of CIMT and help to make it a routine procedure in Primary Care. Ken directs the worldwide sales and business development efforts at CardioRisk.
Amy L. Doneen, ARNP, DNP is an international leader in the prevention of heart attacks, strokes and diabetes. She is the cofounder and a principal instructor in the BaleDoneen Method, practiced by more than 1,000 healthcare providers around the world. This genetically guided, precision-medicine approach to the prevention, detection and treatment of cardiovascular disease (CVD) has been shown in two recent peer-reviewed studies to halt, stabilize and even reverse CVD, helping people avoid heart attacks and strokes, even if they have already suffered one or more of these events.
Dr. Doneen is the owner and medical director of The Heart Attack & Stroke Prevention Center (HASPC) in Spokane, Washington, a highly sought private clinical practice that serves patients from all over the world using the BaleDoneen Method. Founded in 2003, HASPC was one of the first facilities of its kind in the United States to offer its patients a written guarantee of arterial wellness, stating that if they suffer a heart attack or stroke, they will get a refund of all fees paid that year. To date, the clinic has only had to give one refund, despite serving patients with major risk factors for cardiovascular events, such as high blood pressure, high cholesterol, type 2 diabetes, smoking and obesity, including patients weighing up to 400 pounds.